2,4-Dichlorotoluene

We are 2,4-Dichlorotoluene CAS:95-73-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 95-73-8
Product Name: 2,4-Dichlorotoluene
Other Name:
2,4-Dichlorotoluene
2,4-Dichlor-toluol
2,4-dichloro-1-methyl-benzene
 
Density: 1.2±0.1 g/cm3
Boiling Point: 198.6±20.0 °C at 760 mmHg
Melting Point: -14 °C
Molecular Formula: C7H6Cl2
Molecular Weight: 161.029
Flash Point: 79.4±0.0 °C
Exact Mass: 159.984650
LogP: 3.88
Vapour Pressure: 0.5±0.4 mmHg at 25°C
Index of Refraction: 1.543
Water Solubility: immiscible
 
Specification
Appearance: Colorless clear liquid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Quinacrine dihydrochloride CAS: 69-05-6.
Intermediates of Diclobutrazol CAS: 75736-33-3.
Intermediates of Diniconazole CAS: 83657-24-3.
Be used as pesticide and pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,4-Dichlorotoluene


Related News: The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.3-Cyano-2-fluorobenzoic acid The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.nervonic acid CAS:506-37-6 The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.3-BAEPF CAS:1260032-45-8 Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.

Related Products
Product Name
Cuprous Oxide View Details
2-methyl-5-propan-2-ylaniline Cas:2051-53-8 View Details
methane,5-methoxy-6-methyl-2-phenylchromenylium-7-ol Cas:125536-25-6 View Details
4-chloro-2-methylbenzoic acid manufacturer N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide manufacturer N-methyl-2,4-dinitroaniline manufacturer 1,10-Undecadiene manufacturer 1,6-Diiodododecafluorohexane Cas:375-80-4 manufacturer